
Pardeep Pharmachem Private Limited
About Pardeep Pharmachem Private Limited
Data last updated:
Pardeep Pharmachem Private Limited is a private limited company based in Jalandhar, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 June 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24239PB1997PTC020101. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1.4 Cr and a paid-up capital of ₹1.1 Cr. It was formerly known as Themis Lifescience Private Limited and Oros Pharma Private Limited. It is led by directors Nand Kishore Jain (Managing Director) and Pardeep Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lamba Pind Chowk Bye Pass Jalandhar, Punjab, India – 144001.
As per the financials filed for FY 2021, the company reported a revenue of ₹45,600. For the same year it recorded a net profit of ₹39,683 (net margin 87%) and EBITDA of -₹5,917 (EBITDA margin -13%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Pardeep Pharmachem has undergone 2 name changes throughout its history. The company was previously known as Themis Lifescience Private Limited, and Oros Pharma Private Limited. The current legal name is Pardeep Pharmachem Private Limited.
| Company Name | Status |
|---|---|
| Pardeep Pharmachem Private Limited | Current |
| Themis Lifescience Private Limited | Previous |
| Oros Pharma Private Limited | Previous |
Contact details
Pardeep Pharmachem Private Limited's registered office is in Jalandhar, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressLamba Pind Chowk Bye Pass Jalandhar, Punjab, India – 144001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pardeep Pharmachem Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Pardeep Pharmachem Private Limited
FY 2025 filings availablePardeep Pharmachem Private Limited reported revenue of ₹45,600 for FY 2021.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹45,600 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5,917 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39,683 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -13% | ||||
| Net Profit Margin | 87% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pardeep Pharmachem Private Limited, buy the company report.
Board of directors of Pardeep Pharmachem Private Limited
Pardeep Pharmachem has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pardeep Jain Also directs: Meridian Leathers LLP, Pharose Hospitality Private Limited, Kerkar Agro Private Limited and 5 more | Director | 20 Jun 1997 | 29 Years 5 Months | Current |
| Nand Kishore Jain Also directs: Meridian Leathers LLP, J and K Waxofield LLP, Pharose Hospitality Private Limited and 4 more | Managing Director | 20 Jun 1997 | 29 Years 5 Months | Current |
Auditor
Pardeep Pharmachem Private Limited is audited by SURINDER MAHAJAN & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURINDER MAHAJAN & ASSOCIATES | FY 2021 | 009973N |
Shareholding
The shareholding of Pardeep Pharmachem Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pardeep Pharmachem Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pardeep Pharmachem Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pardeep Pharmachem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pardeep Pharmachem has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Pardeep Pharmachem Private Limited, buy the company report.
Recent activity
Pardeep Pharmachem Private Limited has 4 board changes on record since 1997: 2 appointments and 2 cessations. The latest: Gaurang Hasmukhlal Thanawala ceased to be Director on 13 Dec 2014.
Frequently asked questions
Pardeep Pharmachem is an active private limited company based in Jalandhar, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 June 1997 (29+ years old) and is registered under CIN U24239PB1997PTC020101.
Pardeep Pharmachem has 2 current directors:
- Nand Kishore Jain - Managing Director
- Pardeep Jain - Director
The latest financial statements of Pardeep Pharmachem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Pardeep Pharmachem has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Pardeep Pharmachem is U24239PB1997PTC020101. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pardeep Pharmachem was incorporated on 20 June 1997, making it 29+ years old. It is registered with the Registrar of Companies, Chandigarh.
Gaurang Hasmukhlal Thanawala ceased to be Director on 13 Dec 2014. Navita Gupta ceased to be Director on 31 Mar 2007. Nand Kishore Jain was appointed as Managing Director on 20 Jun 1997. Pardeep Pharmachem has 4 board changes on record in total.
The registered office of Pardeep Pharmachem is at Lamba Pind Chowk Bye Pass Jalandhar, Punjab, India – 144001.
Pardeep Pharmachem operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Pardeep Pharmachem is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.

